Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
-
호주 아들레이드, July 10, 2026 (GLOBE NEWSWIRE) -- 호주에 본사를 둔 글로벌 임상시험수탁기관(CRO)인 아반스 클리니컬(Avance Clinical)은 7월 15일부터 19일까지 대만 타이베이 난강전시센터(Taipei Nangang Exhibition Center, TaiNEX)에서 열리는 'BIO Asia–Taiwan...
-
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
-
Quoin Pharmaceuticals (NASDAQ: QNRX) receives FDA IND clearance for a Phase 2 study of QRX003 in Peeling Skin Syndrome, with initiation expected in 2H 2026
-
Tekton Research and Summit Clinical Research Solutions Expand Partnership, Bring MASH Trials to Ohio
Tekton Research, a multi-specialty clinical research site organization, is expanding its partnership with Summit Clinical Research Solutions (“Summit”).
-
SplashBIO Launches as an Independent Platform Company for Biomarker-Driven Clinical Trial Enrollment
SplashBIO™ brings biomarker pre-screening to the front of the clinical trial — built to reduce screen failures and accelerate enrollment.
-
– Official FDA minutes confirm the previously announced End-of-Phase 2 meeting outcomes and provide additional detail on the planned Phase 3 protocol — – FDA agreed that a single pivotal Phase 3...
-
Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease
Pivotal Phase 3 trial enrolls 850 patients, exceeding original projections Study completion on track: symptomatic data readout - Q1 2027, disease-modifying data readout - Q1 2028 Company positions...
-
The Alberta Cancer Foundation is investing $35-million to advance cancer clinical trials in Alberta.
-
Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "Investigator Payment Management Solutions Market Size, Share & Trends Analysis Report by Component, Deployment, Functionality, End Use, Payment,...